Prevalence and Correlates of Chronic Kidney Disease in a Group of Patients with Hypertension in the Savanah Zone of Cameroon: a Cross-sectional Study in Sub-Saharan Africa
Overview
Authors
Affiliations
Background: The prevalence of chronic kidney disease (CKD) is increasing worldwide due to an increase in the risk factors such as hypertension. The greatest burden is in low-income settings, coupled with late diagnosis and limited management resources. This work aimed at studying the prevalence and risk factors of CKD in a group of patients with hypertension in the Savanah zone in Sub-Saharan Africa (SSA).
Methods: We carried out a cross-sectional study between January and May 2016 in the regional Hospital of Garoua-Cameroon. Participants were adults ≥18 years of both sexes, who had a diagnosis of hypertension. Patients underwent a comprehensive clinical, biological, and electrocardiographic evaluation.
Results: A total of 400 patients with hypertension were included, of whom 132 (33%; 95% CI: 28.6-37.8%) were males. Their mean age was 54.16±11.17 years. Hypertension was controlled in 122 (30.5%; 95% CI: 26.2-35.2%) participants. Twelve percent had a positive urine dipstick for proteins. The mean glomerular filtration rate (GFR) was 75.27±24.87 mL/min/1.73m. The prevalence of CKD was seen in 129 (32.3%; 95% CI: 27.9-36.98) participants. Stage 3A was the most frequent (62.01%). The main comorbidities were anemia (44.5%), obesity (39.75%), diabetes (32%), consumption of traditional medicines (15.75%), and hyperuricemia (10.75%). After multivariate analysis, age >50 years (aOR: 1.75; 95% CI: 1.06-2.89; P=0.027), female sex (aOR: 2.21; 95% CI: 1.29-3.78; P=0.0035), obesity (aOR: 1.58, 95% CI: 1.01-2.44; P=0.026) and the hyperuricemia (aOR: 3.67; 95% CI: 1.78-7.58; P<0.001) were independently associated with CKD.
Conclusions: The prevalence of CKD in adults with hypertension was high. This was associated with age greater than 50 years, female sex, obesity and the hyperuricemia.
Habtu B, Ayele G, Belay H, Abrar S, Abebe D, Chekole N BMC Nephrol. 2024; 25(1):259.
PMID: 39134947 PMC: 11320772. DOI: 10.1186/s12882-024-03700-0.
Alshahrani M, Almalki L, Hasoosah N, Alahmari A, Alqahtani A, Alqahtani A Ann Med Surg (Lond). 2024; 86(7):3909-3916.
PMID: 38989199 PMC: 11230802. DOI: 10.1097/MS9.0000000000001755.
Obesity and CKD in Sub-Saharan Africa: A Narrative Review.
Oluyombo R, Oguntade H, Soje M, Obajolowo O, Karim M Kidney Med. 2022; 4(2):100403.
PMID: 35243313 PMC: 8861962. DOI: 10.1016/j.xkme.2021.11.001.
Jingi A, Nkoke C, Noubiap J, Teuwafeu D, Mambap A, Nkouonlack C BMC Nephrol. 2022; 23(1):8.
PMID: 34979971 PMC: 8722319. DOI: 10.1186/s12882-021-02641-2.
Chronic kidney disease in Cameroon: a scoping review.
Aseneh J, Kemah B, Mabouna S, Njang M, Ekane D, Agbor V BMC Nephrol. 2020; 21(1):409.
PMID: 32967645 PMC: 7510319. DOI: 10.1186/s12882-020-02072-5.